Immunotherapy for multiple sclerosis.
作者信息
Hughes R A
出版信息
J Neurol Neurosurg Psychiatry. 1994 Jan;57(1):3-6. doi: 10.1136/jnnp.57.1.3.
Abstract
摘要
相似文献
1
Immunotherapy for multiple sclerosis.多发性硬化症的免疫疗法。
J Neurol Neurosurg Psychiatry. 1994 Jan;57(1):3-6. doi: 10.1136/jnnp.57.1.3.
2
Current disease-modifying therapies in multiple sclerosis.目前用于治疗多发性硬化症的疾病修正疗法。
Semin Neurol. 2003 Jun;23(2):133-46. doi: 10.1055/s-2003-41138.
3
New treatments and azathioprine in multiple sclerosis.多发性硬化症的新疗法与硫唑嘌呤
Lancet. 1997 Oct 4;350(9083):1033. doi: 10.1016/S0140-6736(05)64085-8.
4
Multiple sclerosis.多发性硬化症
Clin Evid. 2005 Dec(14):1637-51.
5
Multiple sclerosis.多发性硬化症
Clin Evid. 2003 Jun(9):1459-73.
6
Effects of interferon beta, cyclophosphamide and azathioprine on cytokine profile in patients with multiple sclerosis.干扰素β、环磷酰胺和硫唑嘌呤对多发性硬化症患者细胞因子谱的影响。
Int J Immunopathol Pharmacol. 2005 Apr-Jun;18(2):377-83. doi: 10.1177/039463200501800219.
7
Immunotherapy in multiple sclerosis, Part 2.多发性硬化症的免疫疗法，第2部分。
Am J Health Syst Pharm. 1995 Oct 1;52(19):2105-20; quiz 2132-4. doi: 10.1093/ajhp/52.19.2105.
8
Interferon, azathioprine and corticosteroids in multiple sclerosis: 6-year follow-up of the ASA cohort.干扰素、硫唑嘌呤和皮质类固醇治疗多发性硬化症：ASA队列的6年随访
Clin Neurol Neurosurg. 2012 Sep;114(7):940-6. doi: 10.1016/j.clineuro.2012.02.014. Epub 2012 Mar 7.
9
Disease-modifying drugs for multiple sclerosis: a rapid and systematic review.用于治疗多发性硬化症的疾病修正药物：一项快速系统评价
Health Technol Assess. 2000;4(9):i-iv, 1-101.
10
Acute multiple sclerosis characterized by extensive mononuclear phagocyte infiltration.
Neurochem Res. 2000 Nov;25(11):1517-20. doi: 10.1023/a:1007636427861.
引用本文的文献
1
Outcomes assessment of drug treatment in multiple sclerosis clinical trials.多发性硬化症临床试验中药物治疗的疗效评估
Pharmacoeconomics. 1996 Mar;9(3):198-210. doi: 10.2165/00019053-199609030-00003.
2
More immunotherapy for multiple sclerosis.更多用于治疗多发性硬化症的免疫疗法。
J Neurol Neurosurg Psychiatry. 1996 Sep;61(3):239-41. doi: 10.1136/jnnp.61.3.239.
3
Neurology.神经病学
BMJ. 1994 Aug 6;309(6951):392-5. doi: 10.1136/bmj.309.6951.392.
本文引用的文献
1
Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group.干扰素β-1b对复发缓解型多发性硬化有效。II. 一项多中心、随机、双盲、安慰剂对照试验的MRI分析结果。英属哥伦比亚大学多发性硬化/MRI研究组和干扰素β多发性硬化研究组。
Neurology. 1993 Apr;43(4):662-7. doi: 10.1212/wnl.43.4.662.
2
Interferon beta in multiple sclerosis.多发性硬化症中的β干扰素
Neurology. 1993 Apr;43(4):641-3. doi: 10.1212/wnl.43.4.641.
3
Intermittent cyclophosphamide pulse therapy in progressive multiple sclerosis: final report of the Northeast Cooperative Multiple Sclerosis Treatment Group.间歇性环磷酰胺脉冲疗法治疗进展型多发性硬化症：东北多发性硬化症协作治疗组的最终报告
Neurology. 1993 May;43(5):910-8. doi: 10.1212/wnl.43.5.910.
4
Methylprednisolone in multiple sclerosis: a comparison of oral with intravenous therapy at equivalent high dose.甲基泼尼松龙治疗多发性硬化症：等效高剂量口服与静脉治疗的比较
J Neurol Neurosurg Psychiatry. 1993 Nov;56(11):1219-20. doi: 10.1136/jnnp.56.11.1219.
5
Double-blind pilot trial of oral tolerization with myelin antigens in multiple sclerosis.多发性硬化症中髓鞘抗原口服耐受的双盲试点试验。
Science. 1993 Feb 26;259(5099):1321-4. doi: 10.1126/science.7680493.
6
Systemic alpha-interferon therapy of multiple sclerosis.多发性硬化症的全身α-干扰素治疗
Neurology. 1984 Oct;34(10):1273-9. doi: 10.1212/wnl.34.10.1273.
7
"Bolus" methylprednisolone versus ACTH in the treatment of multiple sclerosis.大剂量甲基强的松龙与促肾上腺皮质激素治疗多发性硬化症的对比
Ital J Neurol Sci. 1983 Jun;4(2):169-72. doi: 10.1007/BF02043900.
8
Intensive immunosuppression in progressive multiple sclerosis. A randomized, three-arm study of high-dose intravenous cyclophosphamide, plasma exchange, and ACTH.进展性多发性硬化症的强化免疫抑制治疗。一项关于大剂量静脉注射环磷酰胺、血浆置换和促肾上腺皮质激素的随机三臂研究。
N Engl J Med. 1983 Jan 27;308(4):173-80. doi: 10.1056/NEJM198301273080401.
9
Cooperative study in the evaluation of therapy in multiple sclerosis. ACTH vs. placebo--final report.多发性硬化症治疗评估的合作研究。促肾上腺皮质激素与安慰剂——最终报告。
Neurology. 1970 May;20(5):1-59. doi: 10.1212/wnl.20.5_part_2.1.
10
[Side effects of azathioprine (Imurel). Apropos of 313 patients treated for multiple sclerosis. Review of the literature].
Therapie. 1985 May-Jun;40(3):195-202.
Zotero 插件